HeyJaredMPN Hub
The MPN Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in MPN.
- Indexed episodes, last 90 days
- 10
- Latest publication
- Aug 4, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Symposium | Advanced systemic mastocytosis: Therapeutic landscape: Evidence-based strategies across the disease spectrum (opens the original)
Read excerpt
At the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the MPN Hub held a symposium, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. During the symposium, Alessandro Vannucchi, University of Florence, Florence, IT, discussed evidence-based treatment strategies across the disease spectrum of advanced systemic mastocytosis (AdvSM). In this presentation, Vannucchi reviews the evolving therapeutic landscape in AdvSM, h
Symposium | Looking ahead: Future directions and unanswered questions in AdvSM (opens the original)
Read excerpt
At the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the MPN Hub held a symposium, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. The symposium closed with a panel Q&A session with live audience participation. The panelists, Deepti H Radia, Andreas Reiter, Johannes Lübke, and Alessandro Vannucchi, discussed key challenges in advanced systemic mastocytosis (AdvSM), including underdiagnosis and complexities in the
Symposium | Advanced systemic mastocytosis: Diagnosis, risk stratification, and response assessment in 2026 (opens the original)
Read excerpt
At the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the MPN Hub held a symposium, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. During the symposium, Johannes Lübke, University Hospital Mannheim, Mannheim, DE, delivered a presentation on diagnosis, risk stratification, and response assessment in advanced systemic mastocytosis (AdvSM). Lübke discusses the current diagnostic framework for systemic mastocytosis,
Targeting KIT in advanced systemic mastocytosis (opens the original)
Read excerpt
During the MPN Hub Steering Committee Meeting in May 2026, Andreas Reiter, University Hospital Mannheim, Mannheim, DE, delivered a presentation on targeting KIT in advanced systemic mastocytosis (AdvSM). In this presentation, Reiter discusses the rationale for KIT inhibition, and key efficacy and safety data for KIT-targeting therapies in AdvSM. The presentation highlights data from key trials, including the depth of molecular response with KIT-targeting therapies and its correlation with clinic
Symposium | Advanced systemic mastocytosis: Clinical challenges and unmet needs (opens the original)
Read excerpt
At the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the MPN Hub held a symposium, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. During the symposium, Andreas Reiter, University Hospital Mannheim, Mannheim, DE, delivered a presentation on clinical challenges and unmet needs in advanced systemic mastocytosis (AdvSM). In this presentation, Reiter discusses how genetic complexity underpins disease heterogeneity an
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.